Department of Colorectal Surgery, St Vincent's Hospital, Melbourne, Australia.
, 201 W Center St, Rochester, MN, 55902, USA.
Tech Coloproctol. 2018 Apr;22(4):255-263. doi: 10.1007/s10151-018-1781-6. Epub 2018 Apr 20.
Retrorectal tumors are rare tumors that require resection for symptoms, malignancy and potential malignant transformation. Traditional approaches have included laparotomy, perineal excision or a combination. Multiple minimally invasive techniques are available which have the potential to minimize morbidity and enhance recovery. We performed a systematic review of the literature to determine the feasibility and surgical outcomes of retrorectal tumors approached using minimally invasive surgical techniques. Publications in which adult patients (≥ 18 years) had a minimally invasive approach (laparoscopic or robotic) for resection of a primary retrorectal tumor were included. Data were collected on approach, preoperative investigation, size and sacral level of the tumor, operating time, length of stay, perioperative complications, margins and recurrence. Thirty-five articles which included a total of 82 patients met the inclusion criteria. The majority of patients were female (n = 65; 79.2%), with a mean age of 41.7 years (range 18-89 years). Seventy-three patients (89.0%) underwent laparoscopic or combined laparoscopic-perineal resection, and 9 (10.8%) had a robotic approach. The conversion rate was 5.5%. The overall 30-day morbidity rate was 15.7%, including 1 intraoperative rectal injury (1.2%). Ninety-five percent (n = 78) of the retrorectal tumors were benign. Median length of stay was 4 days for both laparoscopic and robotic groups, with ranges of 1-8 and 2-10 days, respectively. No tumor recurrence was noted during follow-up [median 28 months (range 5-71 months)]. A minimally invasive approach for the resection of retrorectal tumors is feasible in selected patients. Careful patient selection is necessary to avoid incomplete resection and higher morbidity than traditional approaches.
直肠后肿瘤较为罕见,当出现症状、具有恶性潜能或发生恶变时,通常需要手术切除。传统的治疗方法包括经腹、经会阴或联合入路切除。目前有多种微创技术可供选择,这些技术有降低发病率和促进康复的潜力。我们对文献进行了系统回顾,以确定微创技术治疗直肠后肿瘤的可行性和手术结果。纳入标准为:采用微创(腹腔镜或机器人)方法切除原发性直肠后肿瘤的成年患者(≥18 岁)。收集的数据包括手术入路、术前检查、肿瘤大小和骶骨水平、手术时间、住院时间、围手术期并发症、切缘和复发情况。共有 35 篇文章,总计 82 例患者符合纳入标准。大多数患者为女性(n=65;79.2%),平均年龄 41.7 岁(18-89 岁)。73 例(89.0%)患者接受腹腔镜或联合腹腔镜-会阴切除术,9 例(10.8%)患者采用机器人辅助手术。中转率为 5.5%。总的 30 天发病率为 15.7%,包括 1 例术中直肠损伤(1.2%)。95.0%(n=78)的直肠后肿瘤为良性。腹腔镜组和机器人组的中位住院时间分别为 4 天(范围 1-8 天)和 4 天(范围 2-10 天)。随访期间未发现肿瘤复发[中位随访时间 28 个月(范围 5-71 个月)]。对于选择合适的患者,微创方法切除直肠后肿瘤是可行的。为避免不完全切除和高于传统方法的发病率,必须仔细选择患者。